Article

Neuropsychiatric side-effects of lidocaine: examples from the treatment of headache and a review.

Headache Group-Department of Neurology, University of California, San Francisco, San Francisco, CA 94115, USA.
Cephalalgia (Impact Factor: 3.49). 02/2009; 29(5):496-508. DOI: 10.1111/j.1468-2982.2008.01800.x
Source: PubMed

ABSTRACT Lidocaine has been used in treatment of patients with refractory headache. Personal observations of neuropsychiatric toxicity in these patients led us to review our cases and the literature systematically for lidocaine side-effects, especially neuropsychiatric symptoms. In our series of 20 patients, side-effects were observed in all, the most frequent being neuropsychiatric (75%) and cardiological (50%). When reviewing published series on intravenous lidocaine use, reports of side-effects range from 0 to 100%, with neuropsychiatric symptoms being reported in 1.8-100%. Thirty-six case reports of lidocaine-induced psychiatric symptoms were also analysed. Psychiatric symptoms of toxicity were similar in most patients, despite their differing ages, pathologies, co-therapies and lidocaine dosages. In conclusion, lidocaine neuropsychiatric toxicity has a well-recognized stereotypical clinical presentation that is probably unrecognized in headache series. As lidocaine represents an emerging alternative therapy in headache, particularly in short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing, clinicians and patients should be aware of the extent of this problem.

1 Bookmark
 · 
133 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The goal of this review is to provide guidelines for evaluating psychiatric and mood changes that result from neurotoxicity. Mood changes that are often seen to varying degrees in neurotoxicity include increased anxiety, depression, irritability, impulsiveness, and psychosis. Some common agents that induce neurotoxicity include drugs, heavy metals, and organophosphates with presentations varying somewhat depending upon the mechanism of toxicity. The authors discuss in detail psychiatric assessment for patients with suspected of having neurotoxicologic syndrome.
    The Psychiatric clinics of North America 06/2013; 36(2):201-208. · 1.87 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Heart rate irregularities are the major limitations of computed tomographic coronary angiography (CTCA) due to severe motion artifacts. To evaluate the safety and efficacy of a lidocaine intravenous bolus in preserving good image quality by the transient suppression of premature ventricular contractions (PVC) during the CTCA scan. The study group comprised 67 consecutive patients with sinus rhythm and numerous PVC scheduled for CTCA. Intravenous boluses of 25-50 mg lidocaine were given after calcium score assessment and immediately before CTCA. The control group comprised 67 patients with sinus rhythm without PVC matched according to the body mass index (BMI), age, sex, and calcium score. All coronary vessel segments were assessed for image quality and presence of significant stenosis. As compared with calcium score assessment, after administration of lidocaine and during the CTCA scan PVC were completely suppressed in 22 (40%), reduced in 10 (18%), unchanged in 18 (32%), and intensified in 5 (10%) patients. Overall, there were 32 (58%) patients with sinus rhythm during CTCA as compared with only 11 (20%) patients free from PVC during calcium score assessment (p < 0.001). Image quality in 871 coronary segments including both the study group and control patients was worse in patients with PVC (p < 0.0001). However, there was no statistically significant difference in the number of patients with at least one segment of non-diagnostic quality (6% vs. 12%, p = 0.36; respectively). Single lidocaine bolus given prior to CTCA is safe, may temporarily eliminate or reduce the intensity of arrhythmia, and hence results in improved quality of CTCA in patients with numerous PVC.
    Postepy w Kardiologii Interwencyjnej / Advances in Interventional Cardiology 01/2013; 9(3):199-204. · 0.16 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction Since quality improvement programs are now mandatory, we decided to put it in practice in our pain day care unit. Objective To realize a quality improvement program on the clinical practices in our pain day care unit and to obtain our certification. Method (1) Plan: bibliography review, as well as a review of procedures in our pain day care unit; clinical pathway choice; (2) Do: realization from November 2007 to November 2009, with three physicians in the pilot committee; a multidisciplinary team meeting was organized to validate intravenous lidocaïne indications; creation of documents and a 10-item questionnaire; (3) Check and act: three audits were made; the health economics data was collected with our medical informatics system program. Results Between the first and last round of the audit, compliance with quality criteria increased significantly from 45–95 % to 80–100 %, depending on the item. After an initial 36 % reduction in 2008, the recruitment level at the end of the program was identical to that before program implementation. A clear increase in activity-based funding was observed at the end of the program (+77 %) for the same period. Discussion Our programme led to an improvement in practice. Financial savings resulted from activity-based costing after the creation of a “disease-related group” for refractory chronic pain but also from compensation of the initial fall in activity by a better occupancy rate in the day hospital. Conclusion The clinical pathway is a simple and effective method of optimizing clinical practices in pain clinics with the use of potential iatrogenic treatment.
    Douleurs Evaluation - Diagnostic - Traitement 01/2010; 11(3):107-115.

Full-text (2 Sources)

Download
49 Downloads
Available from
Jun 2, 2014